In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent
2009

Killing Staphylococcus aureus with Light-Activated Antimicrobial Agent

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Zolfaghari Parjam S, Packer Samantha, Singer Mervyn, Nair Sean P, Bennett Jon, Street Cale, Wilson Michael

Primary Institution: University College London

Hypothesis

Can photodynamic therapy using methylene blue effectively kill methicillin-resistant Staphylococcus aureus in mouse wound models?

Conclusion

Photodynamic therapy is effective at reducing the number of viable MRSA in wounds without causing collateral damage to host tissues.

Supporting Evidence

  • Photodynamic therapy resulted in a 25-fold reduction in viable MRSA in excision wounds.
  • Histological examination showed no significant tissue necrosis after treatment.
  • The study used a well-characterized strain of MRSA known to cause wound infections.

Takeaway

This study shows that shining a special light on a dye can help kill bad bacteria in wounds, which is important because some bacteria are resistant to regular medicine.

Methodology

Mice were treated with methylene blue and laser light, and the number of viable bacteria in wounds was measured.

Potential Biases

Potential bias due to the involvement of authors with financial interests in the technology being tested.

Limitations

The study was conducted in mice, and results may not directly translate to humans.

Participant Demographics

Eight-week old female C57 Black mice, weighing 14–18 g.

Statistical Information

P-Value

0.002

Statistical Significance

p<0.008

Digital Object Identifier (DOI)

10.1186/1471-2180-9-27

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication